Biotechnology VALUE FUND II L.P., 10% Owner, Director at INFINITY PHARMACEUTICALS, INC. (INFI), bought 1,481,249 shares at $1.34 ($2.0M) on 2016-12-28, disclosed to the SEC on 2016-12-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.34 | 77,076 | $103K | 5.2% |
| 2 | $1.34 | 77,076 | $103K | 5.2% |
| 3 | $1.34 | 260,046 | $348K | 17.6% |
| 4 | $1.34 | 260,046 | $348K | 17.6% |
| 5 | $1.34 | 401,726 | $538K | 27.1% |
| 6 | $1.34 | 401,726 |
| $538K |
| 27.1% |
| 7 | $1.34 | 1,205 | $2K | 0.1% |
| 8 | $1.34 | 2,348 | $3K | 0.2% |
| Total | $1.34 avg | 1,481,249 | $2.0M | 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |